Articles

1. Results from a first-in-human phase i safety trial to evaluate the use of a vascularized pericranial/temporoparietal fascial flap to line the resection cavity following resection of newly diagnosed glioblastoma

   • Omer Doron
   • Tamika Wong
   • John A. Boockvar

   Research Open access 26 April 2024

   

2. Pre-treatment systemic inflammation response index and systemic immune inflammation in patients with primary central nerve system lymphoma as a useful prognostic indicator

   • Ryosuke Matsuda
   • Ryosuke Maeoka
   • Ichiro Nakagawa

   Research 25 April 2024

   

3. PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor

   • Shizun Wang
   • Dan Zhang
   • Yuqin Liu

   Research 25 April 2024

   

4. Exploring the impact of primary care utilization and health information exchange upon treatment patterns and clinical outcomes of glioblastoma patients

   • Megan Parker
   • Foad Kazemi
   • Debraj Mukherjee

   Research 25 April 2024

   

5. Correction to: Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness status

   • Johanna Jost
   • Klaus Völker
   • for the MMH Trial Investigators

   Correction Open access 24 April 2024

6. Single versus multiple reoperations for recurrent intracranial meningiomas

   • Francesco Maiuri
   • Sergio Corvino
   • Marialaura Del Basso De Caro

   Case Study Open access 24 April 2024

7. Intraoperative radiotherapy combined with spinal stabilization surgery—a novel treatment strategy for spinal metastases based on a first single-center experiences

   • P. Krauss
   • C. L. Wolfert
   • E. Shiban

   Research Open access 23 April 2024

   

8. Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy

   • Ting Sun
   • Bin Liu
   • Yanyan Li

   Research 23 April 2024

   

9. Genomic landscape of glioblastoma without IDH somatic mutation in 42 cases: a comprehensive analysis using RNA sequencing data

   • Takanari Okamoto
   • Ryo Mizuta
   • Katsuhiro Masago

   Research 23 April 2024

   

10. Screening and surveillance recommendations for central nervous system hemangioblastomas in pediatric patients with Von Hippel-Lindau disease

    • Anna Laura Knoblauch
    • B.-I. Blaß
    • J.-H. Klingler

    Case Study Open access 22 April 2024

    

11. Impact of concurrent antibody–drug conjugates and radiotherapy on symptomatic radiation necrosis in breast cancer patients with brain metastases: a multicenter retrospective study

    • Yutaro Koide
    • Naoya Nagai
    • Takeshi Kodaira

    Research 22 April 2024

    

12. Comment in reply to Chen et al. Journal of Neuro-Oncology (2023) 165:535–545 “Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study”

    • Gregory J. Czarnota

    Correspondence 19 April 2024

13. Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse

    • Kevin J. Bielamowicz
    • Mary Beth Littrell
    • Murat Gokden

    Case Study Open access 19 April 2024

    

14. Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model

    • Katharina Conrad
    • Ronja Löber-Handwerker
    • Vesna Malinova

    Research Open access 19 April 2024

    

15. National trends in the treatment of adult diffuse midline gliomas: a rare clinical scenario

    • Jay Desai
    • Sujay Rajkumar
    • Rodney E. Wegner

    Research 17 April 2024

    

16. Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)

    • Lucy Gately
    • C. Mesía
    • C. Balana

    Research 17 April 2024

    

17. Neuroradiological features of patients with bilateral macronodular adrenocortical disease and meningiomas associated or not with genetic variants of ARMC5– a case series

    • Arthur Araújo Massoud Salame
    • Helaine Laiz Silva Charchar
    • Maria Candida Barisson Villares Fragoso

    Research 17 April 2024

    

18. Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches

    • Elad Mashiach
    • Juan Diego Alzate
    • Douglas Kondziolka

    Research 17 April 2024

    

19. Rebound growth of BRAF mutant pediatric glioma cells after MAPKi withdrawal is associated with MAPK reactivation and secretion of microglia-recruiting cytokines

    • Daniela Kocher
    • Lei Cao
    • Romain Sigaud

    Research Open access 17 April 2024

    

20. Preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed and resectable glioblastoma

    • Liam Wilson
    • Aline Atallah
    • Joan Miguel Romero

    Correspondence 15 April 2024

21. Comparative analysis of bevacizumab and LITT for treating radiation necrosis in previously radiated CNS neoplasms: a systematic review and meta-analysis

    • Neslihan Nisa Gecici
    • Muhammet Enes Gurses
    • Ashish H. Shah

    Review Open access 15 April 2024

    

22. Tissue biopsy before resection in glioblastoma: is there an opportunity to improve outcomes with liquid biopsies and pre-operative stereotactic radiosurgery?

    • Jason P. Sheehan
    • Daniel M. Trifiletti
    • Eric J. Lehrer

    Correspondence 11 April 2024

23. Correction to: Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study

    • Ko-Ting Chen
    • Chiung-Yin Huang
    • Kuo-Chen Wei

    Correction 10 April 2024 Pages: 371 - 371

24. Profile of miRNAs in small extracellular vesicles released from glioblastoma cells treated by boron neutron capture therapy

    • Natsuko Kondo
    • Tadatoshi Kinouchi
    • Minoru Suzuki

    Research 10 April 2024

    

25. Gamma knife radiosurgery for clival metastasis: case series and systematic review

    • Sakibul Huq
    • Regan M. Shanahan
    • L. Dade Lunsford

    Case Study 10 April 2024

    

26. Assessment of multimodal treatment options in recurrent and persistent acromegaly: a systematic review and meta-analysis

    • Seyed Farzad Maroufi
    • Manijeh Assar
    • Hamid Borghei-Razavi

    Review 08 April 2024

    

27. Intraoperative magnetic resonance imaging in glioma surgery: a single-center experience

    • Leyla Mirzayeva
    • Murat Uçar
    • Esra Temel

    Research Open access 03 April 2024

    

28. Elevating the findings by substituting in “ISarcoPRM”

    • Ahmad Jasem Abdulsalam
    • Murat Kara
    • Levent Özçakar

    Correspondence 02 April 2024

29. Perioperative psychological distress in patients with intracranial tumors; a single center study

    • Michael-Karl Fehrenbach
    • Florian Wilhelmy
    • Johannes Kasper

    Research 02 April 2024

30. Comparative analysis of the spatial distribution of brain metastases across several primary cancers using machine learning and deep learning models

    • Saeedeh Mahmoodifar
    • Dhiraj J. Pangal
    • Paul K. Newton

    Research 02 April 2024

    

31. Sex differences in adverse events in Medicare individuals ≥ 66 years of age post glioblastoma treatment

    • Mantas Dmukauskas
    • Gino Cioffi
    • Jill S. Barnholtz-Sloan

    Research Open access 02 April 2024

    

32. Pediatric neurosurgical medulloblastoma outcomes in La Paz, Bolivia: How a Lower Middle-Income Country (LMIC) institution in South America compares to the United States

    • Victor M. Lu
    • Jorge Daniel Brun
    • Jorge David Brun

    Research 02 April 2024

    

33. Real-world cost- effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China

    • Yuliang Xiang
    • Yingyao Chen
    • Shimeng Liu

    Research 02 April 2024

    

34. Repurposing mebendazole against triple-negative breast cancer CNS metastasis

    • Adrian J. Rodrigues
    • Sophia B. Chernikova
    • Melanie Hayden-Gephart

    Research Open access 02 April 2024

    

35. Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness status

    • Johanna Jost
    • Klaus Völker
    • for the MMH Trial Investigators

    Research Open access 01 April 2024

    

36. Machine learning-based pathomics signature of histology slides as a novel prognostic indicator in primary central nervous system lymphoma

    • Ling Duan
    • Yongqi He
    • Feng Chen

    Research Open access 01 April 2024

    

37. Loss of methylthioadenosine phosphorylase immunoreactivity correlates with poor prognosis and elevated uptake of ¹¹C-methionine in IDH-mutant astrocytoma

    • Toshihiro Yamamura
    • Kaoru Tamura
    • Taketoshi Maehara

    Case Study 01 April 2024

    

38. Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: a feasible option for patients with large-volume relapse

    • Elissa Tong
    • Patrick Horsley
    • Michael Back

    Research 29 March 2024

    

39. A new updated prognostic index for patients with brain metastases (BMs) treated with palliative whole brain radiotherapy (WBRT) in the era of precision oncology. METASNCore project

    • Pablo Flores-Paco
    • Alicia Vargas-Aliaga
    • Enrique Aranda

    Research 27 March 2024

    

40. A systematic review of extraneural meningioma metastasis: timing, evolution and outlook

    • Gina Watanabe
    • Kurtis Young
    • Paolo Palmisciano

    Review 26 March 2024

    

41. Utility of molecular markers in predicting local control specific to lung cancer spine metastases treated with stereotactic body radiotherapy

    • Dana Shor
    • Alexander V. Louie
    • Hanbo Chen

    Research 25 March 2024 Pages: 275 - 283

    

42. Adjuvant re-irradiation vs. no early re-irradiation of resected recurrent glioblastoma: pooled comparative cohort analysis from two tertiary centers

    • Christoph Straube
    • Stephanie E. Combs
    • David Kaul

    Research Open access 23 March 2024

    

43. Correction to: Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy

    • Carrie E. Andrews
    • Jenny Zilberberg
    • David W. Andrews

    Correction Open access 22 March 2024 Pages: 369 - 369

44. Letter to the editor: Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis

    • Peter G. Zaki
    • Sanjeev Herr
    • Matthew J. Shepard

    Correspondence 22 March 2024 Pages: 363 - 364

45. Palliative care for in-patient malignant glioma patients in Germany

    • Larissa Fink
    • Birgitt van Oorschot
    • Marcel A. Kamp

    Research Open access 20 March 2024 Pages: 323 - 338

    

46. Health-related quality of life and neurocognitive functioning in patients with recurrent glioblastoma treated with intracerebral immune checkpoint inhibition

    • Wietse Geens
    • Nathalie Vanlaer
    • Johnny Duerinck

    Case Study 19 March 2024

    

47. Correction to: Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response

    • Samuel A. Bobholz
    • Alisha Hoefs
    • Peter S. LaViolette

    Correction Open access 18 March 2024 Pages: 243 - 243

48. Comment on “Craniospinal irradiation for CNS leukemia: rates of response and durability of CNS control’’

    • Minqi Wang
    • Minqiang Chen
    • Yumei Ge

    Correspondence 18 March 2024

49. The detrimental effect of biopsy preceding resection in surgically accessible glioblastoma: results from the national cancer database

    • Ping Zhu
    • Pavel S. Pichardo-Rojas
    • Yoshua Esquenazi

    Research 16 March 2024

    

50. Correction to: Prognostic factors analysis of diffuse midline glioma

    • Jing Jiang
    • Wen-bin Li
    • Shao-wen Xiao

    Correction Open access 15 March 2024 Pages: 293 - 293